
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : BNC-1322
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bonac to Begin Human Clinical Tests for Covid-19 Drug in 2021
Details : Governor Ogawa confirmed the effectiveness of the "nucleic acid drug" against viral infections in an experiment using a new coronavirus strain, and finished narrowing down to three types of drug candidates that could be expected to be effective even in s...
Product Name : Undisclosed
Product Type : Oligonucleotide
Upfront Cash : Inapplicable
August 26, 2020
Lead Product(s) : BNC-1322
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
